Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

ConvaTec Group stock

CTEC.L
GB00BD3VFW73
A2AUD3

Price

3.14
Today +/-
+0.06
Today %
+2.02 %
P

ConvaTec Group stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the ConvaTec Group stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the ConvaTec Group stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the ConvaTec Group stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze ConvaTec Group's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

ConvaTec Group Stock Price History

DateConvaTec Group Price
11/20/20243.14 undefined
11/19/20243.08 undefined
11/18/20243.04 undefined
11/15/20243.14 undefined
11/14/20243.13 undefined
11/13/20243.26 undefined
11/12/20243.37 undefined
11/11/20242.79 undefined
11/8/20242.76 undefined
11/7/20242.79 undefined
11/6/20242.79 undefined
11/5/20242.79 undefined
11/4/20242.81 undefined
11/1/20242.78 undefined
10/31/20242.75 undefined
10/30/20242.82 undefined
10/29/20242.88 undefined
10/28/20242.90 undefined
10/25/20242.83 undefined
10/24/20242.87 undefined
10/23/20242.90 undefined
10/22/20242.95 undefined

ConvaTec Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into ConvaTec Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by ConvaTec Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects ConvaTec Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of ConvaTec Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into ConvaTec Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing ConvaTec Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on ConvaTec Group’s growth potential.

ConvaTec Group Revenue, EBIT and net profit per share

DateConvaTec Group RevenueConvaTec Group EBITConvaTec Group Net Income
2029e2.9 B undefined0 undefined0 undefined
2028e2.9 B undefined739.83 M undefined507.18 M undefined
2027e2.74 B undefined680.21 M undefined459.2 M undefined
2026e2.57 B undefined567.79 M undefined399.61 M undefined
2025e2.42 B undefined506.9 M undefined343.76 M undefined
2024e2.3 B undefined459.34 M undefined295.31 M undefined
20232.14 B undefined287 M undefined130.3 M undefined
20222.07 B undefined243.7 M undefined62.9 M undefined
20212.04 B undefined210 M undefined117.6 M undefined
20201.89 B undefined230.5 M undefined112.5 M undefined
20191.83 B undefined219.5 M undefined9.8 M undefined
20181.83 B undefined290.5 M undefined221.6 M undefined
20171.76 B undefined259.6 M undefined158.4 M undefined
20161.69 B undefined180.1 M undefined-202.8 M undefined
20151.65 B undefined236.9 M undefined-93.4 M undefined
20141.73 B undefined285.8 M undefined-127.2 M undefined
20131.7 B undefined336.7 M undefined15.2 M undefined

ConvaTec Group Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (B)DOCUMENTS
201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e
1.71.731.651.691.761.831.831.892.042.072.142.32.422.572.742.92.9
-2.00-4.842.304.503.85-0.273.677.601.673.387.195.496.196.535.95-0.14
55.5952.4851.6452.6153.1754.3753.2054.8055.4054.3457.0553.2250.4547.5144.6042.0942.15
0.950.910.850.890.9410.971.041.131.131.22000000
15-127-93-2021582219112117621302953433994595070
--946.67-26.77117.20-178.2239.87-95.931,144.444.46-47.01109.68126.9216.2716.3315.0410.46-
-----------------
-----------------
1.951.951.951.381.951.961.982.012.032.042.05000000
-----------------
Details

Keystats

ⓘ

Revenue and Growth

The ConvaTec Group Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the ConvaTec Group is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
20132014201520162017201820192020202120222023
                     
275.4237.5273264.1289.3315.6385.8565.4463.4143.897.6
295.5234.7223.8226.8256.4245.6247.1245.2250.6285.1269.8
12.77.28.36.912.68.11844.350.954.255.5
253.7249.8228.9247.5284.5303.3281.8297.1308.8336.9396.1
37.12023.225.532.330.635.626.537.169.351
0.870.750.760.770.880.90.971.181.110.890.87
280.9260.4251.5264.8334330.7406.1438450.3479.8548.5
00000000030.722.9
0000000008.611.7
2.111.911.731.521.491.331.10.990.90.920.94
1.180.971.020.921.071.041.071.11.161.221.3
40.236.934.335.932.34968.560.454.434.126.5
3.613.183.032.742.932.762.642.592.562.72.84
4.493.933.793.513.83.663.613.773.673.593.71
                     
2.252.250.150.240.240.240.240.250.250.250.25
0001.6700.040.070.120.140.170.18
-2.22-2.36-0.35-0.491.351.471.361.361.381.371.38
19.1-119.9-27.2-172.8-58.4-124.2-99.1-46.1-75.7-177.1-122.2
00000000000
0.05-0.22-0.221.251.531.621.571.681.71.611.69
12299.4114.5111.612211690.598.2116.7112.2525.6
183.5166.7141.7138.3117.6105.5198.8235.9225.8234.4251.8
30.923.57.911.65.346.448.872.762.2166.2127
00000000000
73.643.721.538.578.26359.2106.4164.520.320.7
410333.3285.6300323.1330.9397.3513.2569.2533.1925.1
3.723.533.481.741.741.581.521.441.271.281.29
243.8235.2186.9192.2172.2107.1107.8101.487.283.288.2
63.252.360.738.437.123.728.339.152.286.1104.7
4.033.823.721.971.951.711.651.581.411.451.48
4.444.154.012.272.282.042.052.11.981.982.41
4.493.933.793.513.813.673.623.773.683.594.1
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of ConvaTec Group provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand ConvaTec Group's financial health and stability.

Assets

ConvaTec Group's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that ConvaTec Group must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of ConvaTec Group after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into ConvaTec Group's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (B)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20132014201520162017201820192020202120222023
15-127-93-202158221911211762130
189192181181179190209197210209214
00000000-9-250
-305-326-331-318-161-120-33-55-126-165-124
33140834441413060215144104174146
21827025727066614850365570
3240423946353754595235
23014710074306352401399305281367
-39-45-37-67-84-72-61-86-94-144-129
-36-89-36-63-182-80-72-56-206-348-285
3-4304-97-8-1129-112-204-156
00000000000
846-7319-1,739-71-154-158-93-114-149-13
0001.76-0.010-0.01-0.01000
-49-73-84-119-229-252-162-199-237-124
-895.00--27.00-20.00-11.00------
0000-26-74-79-62-85-88-110
144-3735-8252670179-102-319-46
190.3102.162.77221.8279.9340.4313.3211.8137.5238.2
00000000000

ConvaTec Group stock margins

The ConvaTec Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of ConvaTec Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for ConvaTec Group.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the ConvaTec Group's sales revenue. A higher gross margin percentage indicates that the ConvaTec Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the ConvaTec Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the ConvaTec Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the ConvaTec Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the ConvaTec Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the ConvaTec Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

ConvaTec Group Margin History

ConvaTec Group Gross marginConvaTec Group Profit marginConvaTec Group EBIT marginConvaTec Group Profit margin
2029e57.06 %0 %0 %
2028e57.06 %25.49 %17.47 %
2027e57.06 %24.83 %16.76 %
2026e57.06 %22.08 %15.54 %
2025e57.06 %20.93 %14.19 %
2024e57.06 %20.01 %12.86 %
202357.06 %13.4 %6.08 %
202254.35 %11.76 %3.03 %
202155.41 %10.3 %5.77 %
202054.81 %12.17 %5.94 %
201953.23 %12.01 %0.54 %
201854.4 %15.86 %12.1 %
201753.16 %14.71 %8.98 %
201652.6 %10.67 %-12.01 %
201551.64 %14.35 %-5.66 %
201452.52 %16.48 %-7.33 %
201355.57 %19.8 %0.89 %

ConvaTec Group Stock Sales Revenue, EBIT, Earnings per Share

The ConvaTec Group earnings per share therefore indicates how much revenue ConvaTec Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue ConvaTec Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates ConvaTec Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of ConvaTec Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating ConvaTec Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

ConvaTec Group Revenue, EBIT and net profit per share

DateConvaTec Group Sales per ShareConvaTec Group EBIT per shareConvaTec Group Earnings per Share
2029e1.42 undefined0 undefined0 undefined
2028e1.42 undefined0 undefined0.25 undefined
2027e1.34 undefined0 undefined0.23 undefined
2026e1.26 undefined0 undefined0.2 undefined
2025e1.19 undefined0 undefined0.17 undefined
2024e1.13 undefined0 undefined0.14 undefined
20231.04 undefined0.14 undefined0.06 undefined
20221.02 undefined0.12 undefined0.03 undefined
20211.01 undefined0.1 undefined0.06 undefined
20200.94 undefined0.11 undefined0.06 undefined
20190.92 undefined0.11 undefined0 undefined
20180.94 undefined0.15 undefined0.11 undefined
20170.9 undefined0.13 undefined0.08 undefined
20161.23 undefined0.13 undefined-0.15 undefined
20150.85 undefined0.12 undefined-0.05 undefined
20140.89 undefined0.15 undefined-0.07 undefined
20130.87 undefined0.17 undefined0.01 undefined

ConvaTec Group business model

ConvaTec Group is a global leading company specialized in the development and manufacturing of medical products and technologies for chronic diseases and wounds. The company was founded in the UK in 1978 and has since established a strong presence in over 100 markets worldwide. Over time, ConvaTec has become a significant leader in the healthcare industry. The company was originally founded by doctors to develop better therapies for patients with chronic diseases and wounds. It started with the development of skincare products for individuals with impaired skin barrier, such as patients with stoma and incontinence. Today, ConvaTec offers a variety of products and therapies for chronic diseases and wounds. ConvaTec operates its business in multiple product segments, each offering unique products and services. These segments include Advanced Wound Care, Infusion Devices, Stoma Care, and Continence and Critical Care. As a company, ConvaTec places a strong emphasis on innovation and research to continuously improve products and meet new medical needs. Collaborating closely with physicians, nursing staff, and patients is also emphasized. ConvaTec offers a comprehensive product portfolio. Advanced Wound Care includes a wide range of wound care products, including hydrocolloid dressings, foam dressings, and other biological collagen products. Infusion Devices consist of pump systems and catheters for administering fluids, medications, and nutrients over an extended period. Stoma Care produces products that support patients with an artificial opening to continue their daily lives as normally as possible. Continence and Critical Care provide solutions for bladder and bowel management of patients in critical situations, such as intensive care units. ConvaTec has become a leading company in the field of medical products and technologies over the years, thanks to its innovative products and a consistent focus on meeting people's needs. Through the use of new technologies and a strong focus on user feedback, ConvaTec has contributed to improving the lives of patients worldwide. Output: ConvaTec Group is a global leading company specialized in the development and manufacturing of medical products and technologies for chronic diseases and wounds. ConvaTec Group is one of the most popular companies on Eulerpool.com.

ConvaTec Group SWOT Analysis

Strengths

ConvaTec Group PLC has several notable strengths that contribute to its competitive advantage:

  • Strong brand reputation in the healthcare industry.
  • Broad range of high-quality medical products and solutions.
  • Extensive global presence and distribution network.
  • Robust research and development capabilities, facilitating innovation.
  • Strong relationships with healthcare professionals and institutions.
  • Diverse portfolio offering solutions for various medical conditions.

Weaknesses

Despite its strengths, ConvaTec Group PLC also faces certain weaknesses that require attention:

  • Relatively high dependence on a few key clients for substantial revenue.
  • Limited diversification in terms of product offerings and markets served.
  • Potential vulnerability to changes in healthcare regulations and reimbursement policies.
  • Slow response to emerging market trends and technological advancements.
  • Higher production costs compared to some competitors.

Opportunities

ConvaTec Group PLC can explore the following opportunities to further growth and expansion:

  • Increasing global demand for advanced wound care products.
  • Expanding into emerging markets with untapped potential.
  • Partnerships and collaborations with research institutions and healthcare providers.
  • Developing innovative products to address unmet medical needs.
  • Growth potential in the home healthcare market.

Threats

ConvaTec Group PLC should be wary of the following threats that could impact its business:

  • Intense competition from both established and new market entrants.
  • Potential disruptions in the global supply chain.
  • Evolving regulations and increasing pricing pressure in the healthcare industry.
  • Market volatility and economic uncertainties.
  • Rapid technological advancements and the need to stay ahead of competitors.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

ConvaTec Group Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

ConvaTec Group historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

ConvaTec Group shares outstanding

The number of shares was ConvaTec Group in 2023 — This indicates how many shares 2.053 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue ConvaTec Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates ConvaTec Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of ConvaTec Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating ConvaTec Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

ConvaTec Group dividend history and estimates

In 2023, ConvaTec Group paid a dividend amounting to 0.05 USD. Dividend means that ConvaTec Group distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for ConvaTec Group provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify ConvaTec Group’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating ConvaTec Group's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

ConvaTec Group Dividend History

DateConvaTec Group Dividend
2029e0.05 undefined
2028e0.05 undefined
2027e0.05 undefined
2026e0.05 undefined
2025e0.05 undefined
2024e0.05 undefined
20230.05 undefined
20220.05 undefined
20210.04 undefined
20200.04 undefined
20190.05 undefined
20180.04 undefined
20170.01 undefined

ConvaTec Group dividend payout ratio

In 2023, ConvaTec Group had a payout ratio of 98.98%. The payout ratio indicates the percentage of the company's profits that ConvaTec Group distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for ConvaTec Group represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for ConvaTec Group could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate ConvaTec Group's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

ConvaTec Group Payout Ratio History

DateConvaTec Group Payout ratio
2029e109.89 %
2028e111.84 %
2027e110.33 %
2026e107.49 %
2025e117.69 %
2024e105.81 %
202398.98 %
2022148.26 %
202170.19 %
202078.49 %
2019907.46 %
201846.19 %
201712.64 %
201698.98 %
201598.98 %
201498.98 %
201398.98 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for ConvaTec Group.

ConvaTec Group latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/20230.06 0.07  (4.6 %)2023 Q4
6/30/20230.06 0.07  (12.21 %)2023 Q2
12/31/20220.06 0.07  (8.15 %)2022 Q4
6/30/20220.07 0.07  (-10.59 %)2022 Q2
12/31/20210.06 0.06  (-0.99 %)2021 Q4
6/30/20210.07 0.07  (-0.28 %)2021 Q2
12/31/20200.06 0.06  (7.91 %)2020 Q4
6/30/20200.05 0.06  (18.81 %)2020 Q2
12/31/20190.08 0.06  (-20.84 %)2019 Q4
6/30/20190.05 0.06  (18.81 %)2019 Q2
1
2

Eulerpool ESG Scorecard© for the ConvaTec Group stock

Eulerpool World ESG Rating (EESG©)

80/ 100

🌱 Environment

70

👫 Social

99

🏛️ Governance

70

Environment

Scope 1 - Direct Emissions
14,632
Scope 2 - Indirect emissions from purchased energy
23,430
Scope 3 - Indirect emissions within the value chain
459,590
Total CO₂ emissions
38,062
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees62
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

ConvaTec Group shareholders

%
Name
Stocks
Change
Date
19.38964 % Novo Nordisk Foundation395,318,79303/5/2024
5.12247 % Fidelity International104,437,60769,983,0327/30/2024
4.80577 % Artisan Partners Limited Partnership97,980,65803/5/2024
4.78838 % Black Creek Investment Management, Inc.97,626,171-7,314,89710/9/2024
4.77821 % Capital Research Global Investors97,418,76703/5/2024
4.23654 % MFS Investment Management86,375,233-357,65110/1/2024
2.75464 % Pelham Capital Ltd56,161,91103/5/2024
2.28246 % The Vanguard Group, Inc.46,535,148779,7628/5/2024
1.72717 % Norges Bank Investment Management (NBIM)35,213,8933,110,14510/1/2024
1.69022 % Marathon-London34,460,374-64,23510/1/2024
1
2
3
4
5
...
10

ConvaTec Group Executives and Management Board

Mr. Karim Bitar
ConvaTec Group Chief Executive Officer, Executive Director (since 2019)
Compensation 4.34 M
Mr. Jonny Mason
ConvaTec Group Chief Financial Officer, Executive Director (since 2022)
Compensation 1.03 M
Dr. John Mcadam
ConvaTec Group Non-Executive Independent Chairman of the Board
Compensation 326,000
Ms. Margaret Ewing(67)
ConvaTec Group Senior Non-Executive Independent Director
Compensation 118,000
Mr. Brian May(58)
ConvaTec Group Non-Executive Independent Director
Compensation 96,000
1
2
3
4

Most common questions regarding ConvaTec Group

What values and corporate philosophy does ConvaTec Group represent?

ConvaTec Group PLC represents a strong set of values and a customer-centric corporate philosophy. With a focus on improving the lives of patients, ConvaTec is committed to delivering innovative medical products and solutions. They aim to provide high-quality, reliable, and advanced healthcare technologies that meet the diverse and evolving needs of individuals. By leveraging their expertise and collaborative approach, ConvaTec aims to drive positive healthcare outcomes and enhance patient experiences. With a global presence and a dedicated team, they continuously strive to make a difference in the healthcare industry, emphasizing integrity, innovation, and compassion.

In which countries and regions is ConvaTec Group primarily present?

ConvaTec Group PLC is primarily present in various countries and regions worldwide. As a global company, its operations span across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region. With a strong international presence, ConvaTec serves customers and patients in numerous countries, including the United States, Canada, United Kingdom, Germany, France, Italy, Spain, Australia, China, Japan, and many more. By establishing a diverse and extensive geographic footprint, ConvaTec aims to provide its innovative healthcare products and solutions to a broad range of individuals, healthcare professionals, and healthcare systems around the world.

What significant milestones has the company ConvaTec Group achieved?

ConvaTec Group PLC has achieved several significant milestones throughout its history. Some notable achievements include the company's initial public offering (IPO) in 2016, which marked a major milestone in its growth and development. Additionally, ConvaTec has successfully introduced innovative products and solutions in the healthcare industry, such as its advanced wound care products, ostomy care solutions, and continence and critical care products. The company has also expanded its global footprint by establishing a strong presence in various geographical markets, providing healthcare solutions to a wide range of patients worldwide. ConvaTec's commitment to continuous innovation, product development, and global expansion has contributed to its success and reputation in the healthcare industry.

What is the history and background of the company ConvaTec Group?

ConvaTec Group PLC is a well-established global medical products and technologies company. Founded in 1978, it has a rich and extensive history in the healthcare industry. ConvaTec specializes in developing and manufacturing innovative medical devices, including advanced wound care, ostomy care, continence and critical care products. With headquarters in the UK, ConvaTec operates in over 100 countries, serving healthcare professionals and patients worldwide. Over the years, ConvaTec has earned a strong reputation for its high-quality products, commitment to research and development, and dedication to improving patient lives. As a leading player in the medical industry, ConvaTec Group PLC continues to strive for excellence and innovation in healthcare solutions.

Who are the main competitors of ConvaTec Group in the market?

The main competitors of ConvaTec Group PLC in the market are Coloplast A/S, Medtronic plc, and Hollister Incorporated.

In which industries is ConvaTec Group primarily active?

ConvaTec Group PLC is primarily active in the healthcare industry.

What is the business model of ConvaTec Group?

The business model of ConvaTec Group PLC revolves around providing innovative medical products and services. ConvaTec is a global medical technology company that specializes in the development, manufacturing, and distribution of products for the care of chronic conditions. Their diverse product portfolio includes advanced wound care, ostomy care, continence, and critical care products. By focusing on research, development, and collaboration with healthcare professionals, ConvaTec aims to improve the quality of life for patients worldwide. With a commitment to continuous innovation and a customer-centric approach, ConvaTec Group PLC strives to meet the evolving needs of the healthcare industry.

What is the P/E ratio of ConvaTec Group 2024?

The ConvaTec Group P/E ratio is 21.86.

What is the P/S ratio of ConvaTec Group 2024?

The ConvaTec Group P/S ratio is 2.81.

What is the Quality Investing of ConvaTec Group?

The Quality Investing for ConvaTec Group is 3/10.

What is the revenue of ConvaTec Group 2024?

The expected ConvaTec Group revenue is 2.3 B USD.

How high is the profit of ConvaTec Group 2024?

The expected ConvaTec Group profit is 295.31 M USD.

What is the business model of ConvaTec Group

The ConvaTec Group PLC is a British company specializing in medical products and services. It offers a wide range of products in four business areas: ostomy products, continence and intimate hygiene products, wound therapeutics, and infusion and respiratory products. Ostomy Products ConvaTec offers a comprehensive range of ostomy products for people with intestinal diseases such as colon cancer, Crohn's disease, or ulcerative colitis. The products are developed in close collaboration with patients and healthcare professionals to ensure the best fit and user-friendliness. Continence and Intimate Hygiene Products ConvaTec also produces products for continence and intimate hygiene, such as diapers, pads, and skincare products. These products are designed for patients with urinary or fecal incontinence, as well as for people with limited mobility. Wound Therapeutics The wound therapeutics business area includes a wide range of products for wound care, including compression bandages, foam and hydrocolloid dressings, alginates, and silicone gels. These products are used to treat wounds such as pressure ulcers, venous leg ulcers, and surgical wounds. Infusion and Respiratory Products The infusion and respiratory products business area offers a wide range of medical products used in the treatment of lung diseases such as COPD, asthma, and pneumonia. These products include inhalers, oxygen therapy devices, and infusion devices. Additional Services ConvaTec also provides services such as training for healthcare professionals and patients. These trainings cover various areas, including stoma care, wound care, and continence management. Additionally, the company offers consulting services for healthcare professionals. Business Model ConvaTec achieves its business model by identifying needs and challenges in the healthcare industry and developing and manufacturing innovative products and services. The company works closely with healthcare professionals and patients to ensure that the products meet the users' requirements and needs. The company also focuses on a strong presence in the global market, facilitated by strategic acquisitions and partnerships. ConvaTec has offices and distribution centers in over 100 countries worldwide and employs over 9,000 people. Furthermore, ConvaTec places great emphasis on research and development and invests in the development of new products and technologies. The company collaborates closely with universities and research institutions to support its research and development activities. Overall, ConvaTec's business model is focused on developing and globally distributing innovative products and services to meet the needs of healthcare professionals and patients, thereby improving the health and well-being of millions of people.

What is the ConvaTec Group dividend?

ConvaTec Group pays a dividend of 0.05 USD distributed over payouts per year.

How often does ConvaTec Group pay dividends?

The dividend cannot currently be calculated for ConvaTec Group or the company does not pay out a dividend.

What is the ConvaTec Group ISIN?

The ISIN of ConvaTec Group is GB00BD3VFW73.

What is the ConvaTec Group WKN?

The WKN of ConvaTec Group is A2AUD3.

What is the ConvaTec Group ticker?

The ticker of ConvaTec Group is CTEC.L.

How much dividend does ConvaTec Group pay?

Over the past 12 months, ConvaTec Group paid a dividend of 0.05 USD . This corresponds to a dividend yield of about 1.6 %. For the coming 12 months, ConvaTec Group is expected to pay a dividend of 0.05 USD.

What is the dividend yield of ConvaTec Group?

The current dividend yield of ConvaTec Group is 1.6 %.

When does ConvaTec Group pay dividends?

ConvaTec Group pays a quarterly dividend. This is distributed in the months of May, September, May, September.

How secure is the dividend of ConvaTec Group?

ConvaTec Group paid dividends every year for the past 0 years.

What is the dividend of ConvaTec Group?

For the upcoming 12 months, dividends amounting to 0.05 USD are expected. This corresponds to a dividend yield of 1.62 %.

In which sector is ConvaTec Group located?

ConvaTec Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von ConvaTec Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ConvaTec Group from 10/4/2024 amounting to 0.014 USD, you needed to have the stock in your portfolio before the ex-date on 8/22/2024.

When did ConvaTec Group pay the last dividend?

The last dividend was paid out on 10/4/2024.

What was the dividend of ConvaTec Group in the year 2023?

In the year 2023, ConvaTec Group distributed 0.046 USD as dividends.

In which currency does ConvaTec Group pay out the dividend?

The dividends of ConvaTec Group are distributed in USD.

All fundamentals about ConvaTec Group

Our stock analysis for ConvaTec Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ConvaTec Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.